Nadia M. J. Rupniak
Corporate Officer/Principal bei Lippincott Williams & Wilkins, Inc.
Profil
Nadia M.
J.
Rupniak currently works at Lippincott Williams & Wilkins, Inc., as Member-Editorial Board.
Dr. Rupniak also formerly worked at Dynogen Pharmaceuticals, Inc., as Senior Director, Merck & Co., Inc., as Senior Investigator, and CoLucid Pharmaceuticals, Inc., as Head-Research & Development from 2006 to 2015.
Dr. Rupniak received her undergraduate degree from the University of Oxford and doctorate degree in 1984 from Institute of Psychiatry, Psychology & Neuroscience.
Aktive Positionen von Nadia M. J. Rupniak
| Unternehmen | Position | Beginn |
|---|---|---|
Lippincott Williams & Wilkins, Inc.
 Lippincott Williams & Wilkins, Inc. Publishing: Books/MagazinesConsumer Services Lippincott Williams & Wilkins, Inc. Publishes health information for physicians, nurses, specialized clinicians and students. The company publishes the information in print format (textbooks, journals) as well as electronic formats (CD-ROM, Internet, and intranets). The company was founded in 1890 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Nadia M. J. Rupniak
| Unternehmen | Position | Ende |
|---|---|---|
| COLUCID PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Corporate Officer/Principal | - |
Ausbildung von Nadia M. J. Rupniak
| University of Oxford | Undergraduate Degree |
| Institute of Psychiatry, Psychology & Neuroscience | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
Lippincott Williams & Wilkins, Inc.
Lippincott Williams & Wilkins, Inc. Publishing: Books/MagazinesConsumer Services Lippincott Williams & Wilkins, Inc. Publishes health information for physicians, nurses, specialized clinicians and students. The company publishes the information in print format (textbooks, journals) as well as electronic formats (CD-ROM, Internet, and intranets). The company was founded in 1890 and is headquartered in Philadelphia, PA. | Consumer Services |
